A-Z Index × Submit A-Z Index × Submit A-Z Index Search Dropdown × Submit Facebook Twitter LinkedIn Syndicate Emerging Infectious Disease journal ISSN: 1080-6059 Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Cite This Article Open modal Citation for Media
Medscape CME ACTIVITY In support of improving patient care, this activity has been planned and implemented by Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Medscape, LLC designates this Journal-based CME activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
All other clinicians completing this activity will be issued a certificate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test with a 75% minimum passing score and complete the evaluation at https://www.medscape.org/journal/eid ; and (4) view/print certificate.
NOTE: It is the policy of Medscape Education to avoid the mention of brand names or specific manufacturers in accredited educational activities. However, trade and manufacturer names in this activity are provided in an effort to provide clarity. The use of brand or manufacturer names should not be viewed as an endorsement by Medscape of any specific product or manufacturer.
Upon completion of this activity, participants will be able to:
Assess the epidemiology and parasitology of trichinellosis
Distinguish the diagnostic criteria for trichinellosis
Identify the attack rate of Trichinella spiralis after exposure in the current study
Bryce Simons, MPH, Technical Writer/Editor, Emerging Infectious Diseases. Disclosure: Bryce Simons, MPH, has no relevant financial relationships.
Charles P. Vega, MD, Health Sciences Clinical Professor of Family Medicine, University of California, Irvine School of Medicine, Irvine, California, USA. Charles P. Vega, MD, has the following relevant financial relationships: consultant or advisor for Boehringer Ingelheim; Exact Sciences; GlaxoSmithKline.
Camden D. Gowler, PhD; Nicole Lee, MPH; Meghan Phillips, BSN, RN; Sarah G. H. Sapp, PhD; Tammra Morrison, BSN, RN, NCCPHN; Melanie D’Angelo, MPH; Margaret A. Neja, BS; Billy A. Watson, PhD; Susan P. Montgomery, DVM, MPH; Anne Straily, DVM, MPH; Carl J. Williams, DVM; Erica Wilson, MD.
Trichinella spp. nematodes are parasites that can cause trichinellosis in humans after consumption of infected, undercooked meat. A November 2024 trichinellosis outb…